Anergis

Quick facts

Marketed products

• AllerT · Immunology / Allergy
  AllerT is an allergen immunotherapy that modulates immune tolerance to specific allergens through a peptide-based approach.

Phase 2 pipeline

• AllerT full dose
• AllerT low dose · Immunology / Allergy
  AllerT is an allergen immunotherapy designed to induce immune tolerance to allergens through low-dose, modified allergen exposure.

Phase 1 pipeline

• AllerT1
• AllerT2
• AllerT3
• AllerT4
• AllerT5
• mix of AllerT1-T2-T3
• mix of AllerT4-T5

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Anergis portfolio CI brief
• Anergis pipeline updates RSS